CVS Health Corporation (CVS) Sees Higher Price Target Despite PBM Pressure
CVS Health Corporation (NYSE:CVS) is among the cheap healthcare stocks to buy heading into 2026. On December 4, Bernstein SocGen Group raised its price target on CVS Health Corporation (NYSE:CVS) to $86.00 from $77.00, while reaffirming its ‘Market Perform’ rating on the stock. The firm attributed the improved guidance to the company’s Aetna business unit,…